{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T23:36:55Z","timestamp":1769729815350,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.neurobiolaging.2020.09.025","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T03:38:44Z","timestamp":1602214724000},"page":"101.e11-101.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Herpes simplex virus and Alzheimer's disease: a Mendelian randomization study"],"prefix":"10.1016","volume":"99","author":[{"given":"Man Ki","family":"Kwok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine Mary","family":"Schooling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1017\/S0317167100044115","article-title":"Limbic predilection in Alzheimer dementia: is reactivated herpesvirus involved?","volume":"9","author":"Ball","year":"1982","journal-title":"Can J. Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib3","first-page":"1961","article-title":"Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic","volume":"45","author":"Bowden","year":"2016","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib4","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/sim.7221","article-title":"A\u00a0framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization","volume":"36","author":"Bowden","year":"2017","journal-title":"Stat. Med."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ije\/dyy258","article-title":"Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption","volume":"48","author":"Bowden","year":"2019","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib8","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1038\/s41467-018-04362-x","article-title":"Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function","volume":"9","author":"Davies","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib9","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib7","series-title":"Anti-viral Therapy in Alzheimer\u2019s Disease","author":"Devanand","year":"2017"},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1017\/S0033291700009053","article-title":"Viruses, brain and immunosuppression","volume":"16","author":"Gannicliffe","year":"1986","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib12","doi-asserted-by":"crossref","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","article-title":"Evaluating the potential role of pleiotropy in Mendelian randomization studies","volume":"27","author":"Hemani","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fnagi.2014.00202","article-title":"Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus","volume":"6","author":"Itzhaki","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","article-title":"Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk","volume":"51","author":"Jansen","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chom.2013.03.010","article-title":"Virus infections in the nervous system","volume":"13","author":"Koyuncu","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ebiom.2018.10.001","article-title":"Re-thinking Alzheimer's disease therapeutic targets using gene-based tests","volume":"37","author":"Kwok","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib6","series-title":"Feasibility and Effects of Valaciclovir Treatment in Persons with Early Alzheimer\u2019s Disease (VALZ-Pilot)","author":"L\u00f6vheim","year":"2016"},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib17","first-page":"939","article-title":"Interaction between cytomegalovirus and herpes simplex virus type 1 associated with the risk of Alzheimer's disease development. Why do so many drugs for Alzheimer's disease fail in development?","volume":"61","author":"Lovheim","year":"2018","journal-title":"Time New Meth. New Pract."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/epirev\/mxs007","article-title":"Can infections cause Alzheimer's disease?","volume":"35","author":"Mawanda","year":"2013","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fphar.2014.00097","article-title":"HSV-1 and Alzheimer's disease: more than a hypothesis","volume":"5","author":"Piacentini","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13073-018-0568-8","article-title":"Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines","volume":"10","author":"Scepanovic","year":"2018","journal-title":"Genome Med."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib23","first-page":"351","article-title":"Herpes viruses increase the risk of Alzheimer's disease: a meta-analysis. Why do so many drugs for Alzheimer\u2019s disease fail in development?","volume":"47","author":"Steel","year":"2015","journal-title":"Time New Meth. New Pract."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41467-017-00257-5","article-title":"Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections","volume":"8","author":"Tian","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbi.2018.11.016","article-title":"The lack of association between herpes simplex virus 1 or Toxoplasma gondii infection and cognitive decline in the general population: an 11-year follow-up study","volume":"76","author":"Torniainen-Holm","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13311-018-0611-x","article-title":"Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections\u2014a nationwide, population-based cohort study in Taiwan","volume":"15","author":"Tzeng","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib27","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1038\/s41598-019-41218-w","article-title":"Human herpes virus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis","volume":"9","author":"Warren-Gash","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib28","article-title":"Guidelines for reporting methodological challenges and evaluating potential bias in dementia research. 2018","author":"Weuve","year":"2015","journal-title":"Alzheimer's Dis. Facts Figures"},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib29","series-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","article-title":"Pathogenesis and disease","author":"Whitley","year":"2007"},{"key":"10.1016\/j.neurobiolaging.2020.09.025_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/1756285610370069","article-title":"Antiviral agents in Alzheimer's disease: hope for the future?","volume":"3","author":"Wozniak","year":"2010","journal-title":"Ther. Adv. Neurol. Disord."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458020303092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458020303092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:37:00Z","timestamp":1759318620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458020303092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":26,"alternative-id":["S0197458020303092"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.09.025","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Herpes simplex virus and Alzheimer's disease: a Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}